Repligen Corporation

Healthcare

NASDAQ:RGEN · NASDAQ Global Select

Market Cap $7.45B Beta 1.08 P/E (TTM) 142.4

$132.02 -2.74%

-$3.66 today

52W Low $100.99High $175.77

Vol 1.22M · Avg 1.08M

EPS (TTM) $0.91Medical - Instruments & Supplies

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+11.08%

Period High

$172.26

Period Low

$102.87

Latest

$132.02

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

DaVita Inc.

NYSE:DVA

$13.61B

Globus Medical, Inc.

NYSE:GMED

$10.25B

Baxter International Inc.

NYSE:BAX

$10.11B

Masimo Corporation

NASDAQ:MASI

$9.42B

Charles River Laboratories International, Inc.

NYSE:CRL

$8.86B

AptarGroup, Inc.

NYSE:ATR

$7.70B

Bio-Rad Laboratories, Inc.

NYSE:BIO

$7.66B

Avantor, Inc.

NYSE:AVTR

$6.49B

Stevanato Group S.p.A.

NYSE:STVN

$4.74B

What is the latest RGEN filing?

The latest filing shown is 4 dated May 18, 2026.

How many recent filings does RGEN have?

Intrinsic Alpha currently shows 20 recent filings for RGEN.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.